| Any serious adverse event | ||
|---|---|---|
| Study | Symptoms | Adverse events/total number of participants |
| Altin 2013 | No patients experienced any serious adverse events | 0/221 |
| Arabgol 2015 | Severe anorexia | 1/18 |
| Ardic 2014 | Serious adverse events | 0/101 |
| Arnold 2004 | Serious adverse events | 3/89 |
| Arnold 2010 | Acute depression and suicide attempt | 1/150 |
| Ashkenasi 2011 | Hallucinations | 1/26 |
| Berek 2011 | Serious adverse events | 4/822 |
| Cherland 1999 | Serious adverse events | 13/98 |
| Chou 2012b | Serious adverse events | 0/230 |
| Cortese 2015 | Serious adverse events | 64/1426 |
| Davari‐Ashtiani 2010 | Serious adverse events | 0/16 |
| Dittmann 2014 | Serious adverse events | 0/247 |
| Döpfner 2011a, OBSEER | Serious adverse events | 21/777 |
| Döpfner 2011b | Serious adverse events | 38/822 |
| Findling 2009 | Serious adverse events | 3/157 |
| Germinario 2013 | Serious adverse events | 7/1098 |
| Gerwe 2009 | Serious adverse events | 2/263 |
| Haertling 2015 | Serious adverse events | 3/239 |
| Hammerness 2009 | Participants affected or at risk | 5/57 |
| Hammerness 2012 | Serious adverse events | 0/10 |
| Hulvershorn 2012 | Serious adverse events | 0/25 |
| Jafarinia 2012 | Serious adverse events | 0/20 |
| Jensen 1999 (MTA) | Serious adverse events | 1/245 |
| Kemner 2005 (FOCUS) | Sudden death | 0/850 |
| Kim 2011 | Serious adverse events | 0/97 |
| Lakic 2012 | Strong depressive symptoms | 1/68 |
| Lee 2014 | Serious adverse events | 542/4055 |
| Li 2011 | Serious adverse events | 0/36 |
| Maayan 2009 | Serious adverse events | 0/8 |
| McCarthy 2009 | Sudden death | 5/5351 |
| McCracken 2016 | Serious adverse events | 0/61 |
| Mohammadi 2004 | Serious adverse events | 3/116 |
| Pierce 2010 | Serious adverse events | 0/71 |
| Remschmidt 2005 | Serious adverse events | 4/89 |
| Schmidt 2002 | Generalized tonic‐clonic seizure | 1/124 |
| Schulz 2010 | Serious adverse events | 0/145 |
| Shin 2016 | Serious adverse events | 1224/123,636 |
| Sobanski 2013 | Serious adverse events | 8/347 |
| Steele 2006 | Serious adverse events | 0/73 |
| Su 2015 | Serious adverse events | 0/239 |
| Valdizán Usón 2013 | Serious adverse events | 0/689 |
| Warshaw 2010 | Serious adverse events | 0/260 |
| Weiss 2007 | Serious adverse events | 0/79 |
| Wigal 2011 | Serious adverse events | 0/31 |
| Wigal 2013 | Serious adverse events | 0/39 |
| Wigal 2015 | Serious adverse events | 1/200 |
| Wilens 2006 | Serious adverse events | 1/87 |
| Wilens 2008 | Serious adverse events | 0/127 |
| Winterstein 2009 | Serious adverse events | 171/18,238 |
| Zheng 2015 | Serious adverse events | 0/149 |